19.04.2023 - EQS-News: ABIVAX / Key word(s): Annual Results Abivax reports 2022 financial results and operations update 19.04.2023 / 21:00 CET/CEST The issuer is solely responsible for the content of this announcement. Abivax reports 2022 financial results and .
Michael Ferguson has a strong track record in the biopharmaceutical industry, having held senior positions for commercialization and marketing of drugs in the field of Gastroenterology and specifically
EQS-News: ABIVAX / Key word: Personnel
Abivax appoints Michael Ferguson as Chief Commerical Officer
18.04.2023 / 18:00 CET/CEST
The issuer is solely responsible for the content. | April 18, 2023